Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gout and hyperuricemia.

R Roubenoff1

  • 1Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Rheumatic Diseases Clinics of North America
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

Gout prevalence is increasing in the US. New evidence suggests gout is an independent risk factor for coronary heart disease (CHD), warranting screening for modifiable risk factors in patients with gout.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of Pharmacotherapies for the Treatment of Sarcopenia.

The Journal of frailty & aging·2019
Same author

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

The Journal of frailty & aging·2018
Same author

Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

The Journal of frailty & aging·2016
Same author

PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.

The Journal of frailty & aging·2015
Same author

Cardiometabolic risks during anabolic hormone supplementation in older men.

Obesity (Silver Spring, Md.)·2013
Same author

Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).

The journal of nutrition, health & aging·2011

Area of Science:

  • Cardiology
  • Rheumatology
  • Epidemiology

Background:

  • Gout prevalence has risen in the US over the past 20 years.
  • Hyperuricemia is a necessary but not sufficient condition for gout.
  • Gout is linked to risk factors like male sex, hypertension, renal insufficiency, obesity, and diuretic use.

Purpose of the Study:

  • To investigate the association between gout and coronary heart disease (CHD).
  • To determine if gout is an independent risk factor for CHD.
  • To evaluate the role of asymptomatic hyperuricemia (AHU) in CHD risk.

Main Methods:

  • Analysis of data from the Framingham Study.
  • Examination of epidemiological trends in gout prevalence.
  • Assessment of risk factors associated with gout and CHD.

Related Experiment Videos

Main Results:

  • Gout is identified as an independent risk factor for CHD.
  • The association between asymptomatic hyperuricemia and CHD appears weak.
  • Evidence suggests a controversial link between gout and CHD.

Conclusions:

  • Patients with gout should be screened for modifiable CHD risk factors.
  • Early intervention in gout patients may be beneficial for CHD prevention.
  • The role of AHU as a CHD risk factor remains unclear but is likely minimal.